Induction Therapy With Autologous Mesenchymal Stem Cells in Living …

Posted: Published on November 1st, 2013

This post was added by Dr. Richardson

Corresponding Author: Jianming Tan, MD, PhD, Fuzhou General Hospital, Xiamen University, 156 Xi Er Huang Road, Fuzhou, Fujian 350025, P.R. China (tanjm156@yahoo.com.cn), and Camillo Ricordi, MD, Diabetes Research Institute and Cell Transplant Center, University of Miami, 1450 NW 10th Ave, Miami, FL 33136 (cricordi@med.miami.edu).

Author Contributions: Drs Tan and Ricordi had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Tan, Wu, Xu, Liao, Zheng, Pileggi, Ricordi.

Acquisition of data: Tan, Wu, Liao, Sun, Chen, Yang, Cai, Gao.

Analysis and interpretation of data: Tan, Wu, Xu, Liao, Zheng, Messinger, Pileggi, Ricordi.

Drafting of the manuscript: Tan, Wu, Xu, Liao, Zheng, Messinger, Pileggi.

Critical revision of the manuscript for important intellectual content: Tan, Wu, Xu, Liao, Zheng, Messinger, Sun, Chen, Yang, Cai, Gao, Pileggi, Ricordi.

Statistical analysis: Tan, Wu, Xu, Liao, Zheng, Messinger, Pileggi.

Obtained funding: Tan.

Administrative, technical, or material support: Tan, Wu, Liao, Sun, Chen, Yang, Cai, Gao.

The rest is here:
Induction Therapy With Autologous Mesenchymal Stem Cells in Living ...

Related Posts
This entry was posted in Mesenchymal Stem Cells. Bookmark the permalink.

Comments are closed.